

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.72842258 |
| 2 | positive regulation of granulocyte differentiation (GO:0030854) | 5.23441092 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.20234503 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.13784454 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.13784454 |
| 6 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.05915787 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.97225649 |
| 8 | response to interleukin-15 (GO:0070672) | 4.91601502 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.90256684 |
| 10 | vocalization behavior (GO:0071625) | 4.89335577 |
| 11 | tolerance induction (GO:0002507) | 4.83617304 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.74554135 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.72295314 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.65278887 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.60352146 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.59360539 |
| 17 | protein localization to synapse (GO:0035418) | 4.54644382 |
| 18 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.51508331 |
| 19 | locomotory exploration behavior (GO:0035641) | 4.49846196 |
| 20 | leukocyte aggregation (GO:0070486) | 4.47906782 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 4.45526663 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.44994722 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.34894448 |
| 24 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.33238914 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.32051291 |
| 26 | neuron cell-cell adhesion (GO:0007158) | 4.28535257 |
| 27 | T cell migration (GO:0072678) | 4.25814144 |
| 28 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.21334948 |
| 29 | regulation of synapse structural plasticity (GO:0051823) | 4.13599997 |
| 30 | negative regulation of T cell mediated immunity (GO:0002710) | 4.11673377 |
| 31 | * alpha-beta T cell differentiation (GO:0046632) | 4.11258799 |
| 32 | negative T cell selection (GO:0043383) | 4.10604391 |
| 33 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.09607187 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.09306878 |
| 35 | exploration behavior (GO:0035640) | 4.05911779 |
| 36 | interferon-gamma production (GO:0032609) | 4.00121847 |
| 37 | dendritic spine morphogenesis (GO:0060997) | 3.99870957 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.97142265 |
| 39 | synaptic transmission, glutamatergic (GO:0035249) | 3.94315695 |
| 40 | synaptic vesicle maturation (GO:0016188) | 3.91528795 |
| 41 | neural tube formation (GO:0001841) | 3.91324796 |
| 42 | neuron-neuron synaptic transmission (GO:0007270) | 3.88993985 |
| 43 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.88724954 |
| 44 | long-term memory (GO:0007616) | 3.87009893 |
| 45 | neuron recognition (GO:0008038) | 3.86059462 |
| 46 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.85977910 |
| 47 | synaptic vesicle exocytosis (GO:0016079) | 3.85173092 |
| 48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.81730107 |
| 49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.81547467 |
| 50 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.80534302 |
| 51 | synaptic transmission, dopaminergic (GO:0001963) | 3.79518595 |
| 52 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.79113091 |
| 53 | histone H3-K4 trimethylation (GO:0080182) | 3.75501164 |
| 54 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.75280984 |
| 55 | Peyers patch development (GO:0048541) | 3.75280984 |
| 56 | behavioral fear response (GO:0001662) | 3.74910103 |
| 57 | behavioral defense response (GO:0002209) | 3.74910103 |
| 58 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.68465270 |
| 59 | regulation of T cell tolerance induction (GO:0002664) | 3.68458310 |
| 60 | * T cell differentiation (GO:0030217) | 3.67989321 |
| 61 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.64039384 |
| 62 | T-helper cell differentiation (GO:0042093) | 3.64039384 |
| 63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.61663190 |
| 64 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.61184934 |
| 65 | * alpha-beta T cell activation (GO:0046631) | 3.60225123 |
| 66 | T cell differentiation involved in immune response (GO:0002292) | 3.57079524 |
| 67 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.57079524 |
| 68 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.57079524 |
| 69 | prepulse inhibition (GO:0060134) | 3.56908735 |
| 70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.56817353 |
| 71 | layer formation in cerebral cortex (GO:0021819) | 3.56650244 |
| 72 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.55044422 |
| 73 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.53455791 |
| 74 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.53455791 |
| 75 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.53455791 |
| 76 | positive regulation of synapse maturation (GO:0090129) | 3.53358618 |
| 77 | regulation of female receptivity (GO:0045924) | 3.53342376 |
| 78 | regulation of postsynaptic membrane potential (GO:0060078) | 3.47718909 |
| 79 | negative regulation of protein oligomerization (GO:0032460) | 3.47206801 |
| 80 | histone H3-K36 demethylation (GO:0070544) | 3.47088342 |
| 81 | dopamine receptor signaling pathway (GO:0007212) | 3.47009874 |
| 82 | axonal fasciculation (GO:0007413) | 3.46968636 |
| 83 | regulation of synaptic plasticity (GO:0048167) | 3.46225611 |
| 84 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.45617306 |
| 85 | negative thymic T cell selection (GO:0045060) | 3.45204869 |
| 86 | positive regulation of membrane potential (GO:0045838) | 3.44784295 |
| 87 | * positive T cell selection (GO:0043368) | 3.44156661 |
| 88 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.43113351 |
| 89 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.41780956 |
| 90 | * T cell selection (GO:0045058) | 3.41410453 |
| 91 | response to histamine (GO:0034776) | 3.39265538 |
| 92 | regulation of dendritic spine development (GO:0060998) | 3.38569196 |
| 93 | positive regulation of tolerance induction (GO:0002645) | 3.38045747 |
| 94 | long-term synaptic potentiation (GO:0060291) | 3.37629767 |
| 95 | fear response (GO:0042596) | 3.36436490 |
| 96 | neuronal action potential propagation (GO:0019227) | 3.36404099 |
| 97 | response to amphetamine (GO:0001975) | 3.36306729 |
| 98 | regulation of regulatory T cell differentiation (GO:0045589) | 3.35986909 |
| 99 | activated T cell proliferation (GO:0050798) | 3.34295914 |
| 100 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.34132943 |
| 101 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.34018667 |
| 102 | transmission of nerve impulse (GO:0019226) | 3.33328733 |
| 103 | signal complex assembly (GO:0007172) | 3.31751515 |
| 104 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31170727 |
| 105 | regulation of granulocyte differentiation (GO:0030852) | 3.29916443 |
| 106 | T cell homeostasis (GO:0043029) | 3.27708090 |
| 107 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.26501002 |
| 108 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.24985880 |
| 109 | glutamate secretion (GO:0014047) | 3.22661328 |
| 110 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.22561925 |
| 111 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.20458133 |
| 112 | thymic T cell selection (GO:0045061) | 3.17584476 |
| 113 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.17183096 |
| 114 | dendritic spine organization (GO:0097061) | 3.15946281 |
| 115 | behavioral response to cocaine (GO:0048148) | 3.15885311 |
| 116 | neurotransmitter secretion (GO:0007269) | 3.14901998 |
| 117 | regulation of glutamate secretion (GO:0014048) | 3.14769550 |
| 118 | positive regulation of neurotransmitter transport (GO:0051590) | 3.14580838 |
| 119 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.14176079 |
| 120 | striatum development (GO:0021756) | 3.13763893 |
| 121 | positive regulation of dendritic spine development (GO:0060999) | 3.12161148 |
| 122 | female mating behavior (GO:0060180) | 3.12010991 |
| 123 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.10918362 |
| 124 | regulation of synaptic vesicle transport (GO:1902803) | 3.09685427 |
| 125 | learning (GO:0007612) | 3.09608314 |
| 126 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.09420900 |
| 127 | regulation of tolerance induction (GO:0002643) | 3.09302758 |
| 128 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.09053403 |
| 129 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.09053403 |
| 130 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.08725801 |
| 131 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.07861368 |
| 132 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.03020329 |
| 133 | postsynaptic membrane organization (GO:0001941) | 3.02632557 |
| 134 | cAMP catabolic process (GO:0006198) | 3.02053087 |
| 135 | regulation of B cell differentiation (GO:0045577) | 3.01402676 |
| 136 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.98293084 |
| 137 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.98293084 |
| 138 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.96437689 |
| 139 | auditory behavior (GO:0031223) | 2.95775499 |
| 140 | positive regulation of interleukin-2 production (GO:0032743) | 2.95615522 |
| 141 | cellular response to interleukin-15 (GO:0071350) | 2.93624923 |
| 142 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.93475545 |
| 143 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.93475545 |
| 144 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93416716 |
| 145 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.92622242 |
| 146 | gamma-aminobutyric acid transport (GO:0015812) | 2.92007695 |
| 147 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.91471571 |
| 148 | lymph node development (GO:0048535) | 2.90716584 |
| 149 | dendrite morphogenesis (GO:0048813) | 2.90614891 |
| 150 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90597720 |
| 151 | histone H4-K16 acetylation (GO:0043984) | 2.90588131 |
| 152 | presynaptic membrane assembly (GO:0097105) | 2.90112653 |
| 153 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.90074486 |
| 154 | mast cell activation (GO:0045576) | 2.89718033 |
| 155 | glycosphingolipid biosynthetic process (GO:0006688) | 2.89490220 |
| 156 | negative regulation of adaptive immune response (GO:0002820) | 2.88807056 |
| 157 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.87453450 |
| 158 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87415238 |
| 159 | * T cell activation (GO:0042110) | 2.86984855 |
| 160 | mast cell activation involved in immune response (GO:0002279) | 2.85439175 |
| 161 | mast cell degranulation (GO:0043303) | 2.85439175 |
| 162 | positive regulation of mRNA catabolic process (GO:0061014) | 2.84830641 |
| 163 | dentate gyrus development (GO:0021542) | 2.83615637 |
| 164 | membrane depolarization (GO:0051899) | 2.82814734 |
| 165 | B cell receptor signaling pathway (GO:0050853) | 2.81762529 |
| 166 | neuromuscular process controlling balance (GO:0050885) | 2.81189241 |
| 167 | regulation of vesicle fusion (GO:0031338) | 2.81000411 |
| 168 | T cell receptor signaling pathway (GO:0050852) | 2.79990169 |
| 169 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.79014574 |
| 170 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.78486058 |
| 171 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.78486058 |
| 172 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.77894601 |
| 173 | regulation of Rap GTPase activity (GO:0032317) | 2.77216692 |
| 174 | histone H3-K4 methylation (GO:0051568) | 2.75895899 |
| 175 | natural killer cell differentiation (GO:0001779) | 2.75733883 |
| 176 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.75632337 |
| 177 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.74010283 |
| 178 | histone H3-K9 modification (GO:0061647) | 2.73308658 |
| 179 | negative regulation of glial cell proliferation (GO:0060253) | 2.71095588 |
| 180 | * lymphocyte differentiation (GO:0030098) | 2.70417028 |
| 181 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.68908610 |
| 182 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.68908610 |
| 183 | regulation of mRNA catabolic process (GO:0061013) | 2.68231207 |
| 184 | peptidyl-lysine trimethylation (GO:0018023) | 2.67362625 |
| 185 | protein K11-linked deubiquitination (GO:0035871) | 2.67047330 |
| 186 | regulation of alpha-beta T cell activation (GO:0046634) | 2.66681388 |
| 187 | positive regulation of isotype switching (GO:0045830) | 2.64820622 |
| 188 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.64133818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.49341027 |
| 2 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.25654565 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.10159015 |
| 4 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.02175483 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.96221552 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.90344023 |
| 7 | * MYB_26560356_Chip-Seq_TH2_Human | 2.73646525 |
| 8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69584374 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69584374 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64324197 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.64104098 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58432780 |
| 13 | * BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.57945570 |
| 14 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53704200 |
| 15 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.53062177 |
| 16 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.51647985 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.48434075 |
| 18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42676116 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37511011 |
| 20 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35616221 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.33858451 |
| 22 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33367342 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.33202868 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.29480881 |
| 25 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23187238 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.16916322 |
| 27 | * MYB_26560356_Chip-Seq_TH1_Human | 2.16882108 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.15460262 |
| 29 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.15397765 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12140117 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07541544 |
| 32 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.02303560 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01801997 |
| 34 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 2.01312826 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.00108125 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.97050312 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.92036198 |
| 38 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.86477187 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82797775 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.82105455 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81336426 |
| 42 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.80453389 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80088970 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78304259 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77417168 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.76913995 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.72573484 |
| 48 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.70484077 |
| 49 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.69890878 |
| 50 | * MAF_26560356_Chip-Seq_TH1_Human | 1.65524583 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.65321645 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.63050226 |
| 53 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.60821137 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59907122 |
| 55 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.58563519 |
| 56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57508024 |
| 57 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53682343 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53584932 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52623157 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.51778738 |
| 61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50121610 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44683864 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42046643 |
| 64 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.40935588 |
| 65 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.40326966 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39519944 |
| 67 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.36657053 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.35425088 |
| 69 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35392842 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.34614959 |
| 71 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.34353368 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.34265155 |
| 73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33220867 |
| 74 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.32911550 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.31419578 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28911998 |
| 77 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28726697 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28685221 |
| 79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27900603 |
| 80 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23292784 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23265520 |
| 82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.22107627 |
| 83 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21433313 |
| 84 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21431953 |
| 85 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21012738 |
| 86 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20063480 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18068022 |
| 88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18065579 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17145500 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16868757 |
| 91 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16294517 |
| 92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16178993 |
| 93 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15476483 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14797133 |
| 95 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14672743 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13065339 |
| 97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12223223 |
| 98 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11157217 |
| 99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10591908 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10441909 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10322341 |
| 102 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09961522 |
| 103 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09793090 |
| 104 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09634347 |
| 105 | * AR_19668381_ChIP-Seq_PC3_Human | 1.09469974 |
| 106 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09386790 |
| 107 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08816390 |
| 108 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08581590 |
| 109 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08058347 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07491156 |
| 111 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07491156 |
| 112 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06489304 |
| 113 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06471222 |
| 114 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06219111 |
| 115 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03991227 |
| 116 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03682980 |
| 117 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03357602 |
| 118 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03116705 |
| 119 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02097551 |
| 120 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01334888 |
| 121 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01237034 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00800664 |
| 123 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00680468 |
| 124 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00178649 |
| 125 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99409958 |
| 126 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98925082 |
| 127 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97526918 |
| 128 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.97312497 |
| 129 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.97039429 |
| 130 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96179914 |
| 131 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95826377 |
| 132 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95813554 |
| 133 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95316875 |
| 134 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95308260 |
| 135 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94936748 |
| 136 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94812443 |
| 137 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94435321 |
| 138 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94400608 |
| 139 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94175767 |
| 140 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94088266 |
| 141 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93637853 |
| 142 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93546903 |
| 143 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93342386 |
| 144 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92899924 |
| 145 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92487607 |
| 146 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92275181 |
| 147 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91514771 |
| 148 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91022321 |
| 149 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90908617 |
| 150 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90374631 |
| 151 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90184789 |
| 152 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90178822 |
| 153 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89865837 |
| 154 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89686826 |
| 155 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89592887 |
| 156 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89540738 |
| 157 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89285759 |
| 158 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87964231 |
| 159 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.87191599 |
| 160 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.87054500 |
| 161 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86258819 |
| 162 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.83515211 |
| 163 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83351472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.55973160 |
| 2 | MP0003880_abnormal_central_pattern | 5.19265964 |
| 3 | MP0002822_catalepsy | 4.87445943 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.16744395 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.57981091 |
| 6 | MP0009745_abnormal_behavioral_response | 3.53757659 |
| 7 | MP0004270_analgesia | 3.23886266 |
| 8 | MP0001800_abnormal_humoral_immune | 3.15179481 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.86201880 |
| 10 | MP0002064_seizures | 2.82043243 |
| 11 | MP0003436_decreased_susceptibility_to | 2.69305672 |
| 12 | MP0003724_increased_susceptibility_to | 2.65756786 |
| 13 | MP0005409_darkened_coat_color | 2.61792732 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.59774300 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.52501232 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.49052350 |
| 17 | MP0001486_abnormal_startle_reflex | 2.47297640 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.42966006 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.34014600 |
| 20 | MP0002272_abnormal_nervous_system | 2.32384068 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.30804307 |
| 22 | * MP0002398_abnormal_bone_marrow | 2.27054183 |
| 23 | * MP0001819_abnormal_immune_cell | 2.26157016 |
| 24 | MP0002723_abnormal_immune_serum | 2.25505030 |
| 25 | MP0001501_abnormal_sleep_pattern | 2.22103867 |
| 26 | MP0005387_immune_system_phenotype | 2.11943333 |
| 27 | MP0001790_abnormal_immune_system | 2.11943333 |
| 28 | MP0003787_abnormal_imprinting | 2.08804092 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 2.07091271 |
| 30 | MP0009046_muscle_twitch | 2.05859040 |
| 31 | MP0001873_stomach_inflammation | 2.05571300 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 2.03275687 |
| 33 | MP0002405_respiratory_system_inflammati | 2.01084517 |
| 34 | * MP0000716_abnormal_immune_system | 1.99950114 |
| 35 | MP0000778_abnormal_nervous_system | 1.99876013 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.99696124 |
| 37 | MP0008057_abnormal_DNA_replication | 1.99187954 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.97869829 |
| 39 | MP0002184_abnormal_innervation | 1.96970215 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.95621654 |
| 41 | MP0008569_lethality_at_weaning | 1.91900136 |
| 42 | * MP0003763_abnormal_thymus_physiology | 1.91507208 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.91194376 |
| 44 | * MP0002722_abnormal_immune_system | 1.88769665 |
| 45 | MP0000685_abnormal_immune_system | 1.88682225 |
| 46 | MP0002736_abnormal_nociception_after | 1.87691378 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.87361999 |
| 48 | MP0001984_abnormal_olfaction | 1.85923076 |
| 49 | * MP0000689_abnormal_spleen_morphology | 1.85691852 |
| 50 | MP0001529_abnormal_vocalization | 1.80191327 |
| 51 | MP0005025_abnormal_response_to | 1.79388144 |
| 52 | MP0001440_abnormal_grooming_behavior | 1.79152190 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.78475723 |
| 54 | MP0002734_abnormal_mechanical_nocicepti | 1.76871081 |
| 55 | MP0004811_abnormal_neuron_physiology | 1.72958924 |
| 56 | MP0004947_skin_inflammation | 1.70098842 |
| 57 | MP0005499_abnormal_olfactory_system | 1.66380716 |
| 58 | MP0005394_taste/olfaction_phenotype | 1.66380716 |
| 59 | MP0002067_abnormal_sensory_capabilities | 1.61284550 |
| 60 | MP0004924_abnormal_behavior | 1.61157897 |
| 61 | MP0005386_behavior/neurological_phenoty | 1.61157897 |
| 62 | MP0001970_abnormal_pain_threshold | 1.60793017 |
| 63 | MP0001188_hyperpigmentation | 1.57238805 |
| 64 | MP0002733_abnormal_thermal_nociception | 1.54958297 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.46138320 |
| 66 | MP0002419_abnormal_innate_immunity | 1.43516331 |
| 67 | * MP0002429_abnormal_blood_cell | 1.42406988 |
| 68 | MP0009785_altered_susceptibility_to | 1.41903162 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.37315120 |
| 70 | MP0008995_early_reproductive_senescence | 1.35851147 |
| 71 | MP0006276_abnormal_autonomic_nervous | 1.35375071 |
| 72 | MP0004381_abnormal_hair_follicle | 1.34548229 |
| 73 | MP0002933_joint_inflammation | 1.34177446 |
| 74 | MP0002909_abnormal_adrenal_gland | 1.33478883 |
| 75 | MP0001851_eye_inflammation | 1.31876603 |
| 76 | MP0004130_abnormal_muscle_cell | 1.30172287 |
| 77 | MP0002882_abnormal_neuron_morphology | 1.30168599 |
| 78 | MP0004510_myositis | 1.28092329 |
| 79 | MP0003329_amyloid_beta_deposits | 1.26679008 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 1.26465358 |
| 81 | MP0003879_abnormal_hair_cell | 1.25174833 |
| 82 | MP0000955_abnormal_spinal_cord | 1.24934171 |
| 83 | MP0002066_abnormal_motor_capabilities/c | 1.19347338 |
| 84 | MP0008961_abnormal_basal_metabolism | 1.13776918 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 1.12592554 |
| 86 | MP0002148_abnormal_hypersensitivity_rea | 1.12072623 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 1.11193827 |
| 88 | MP0002152_abnormal_brain_morphology | 1.10031652 |
| 89 | MP0008789_abnormal_olfactory_epithelium | 1.09930304 |
| 90 | MP0008874_decreased_physiological_sensi | 1.09426658 |
| 91 | MP0001905_abnormal_dopamine_level | 1.06933007 |
| 92 | MP0005646_abnormal_pituitary_gland | 1.06674990 |
| 93 | MP0004883_abnormal_blood_vessel | 1.06072794 |
| 94 | * MP0000703_abnormal_thymus_morphology | 1.03777290 |
| 95 | MP0004742_abnormal_vestibular_system | 1.03025720 |
| 96 | MP0001845_abnormal_inflammatory_respons | 1.01150749 |
| 97 | MP0004858_abnormal_nervous_system | 1.00870940 |
| 98 | MP0004885_abnormal_endolymph | 0.99858484 |
| 99 | MP0006082_CNS_inflammation | 0.99178858 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98697756 |
| 101 | MP0001502_abnormal_circadian_rhythm | 0.98520102 |
| 102 | MP0003121_genomic_imprinting | 0.94844701 |
| 103 | MP0003633_abnormal_nervous_system | 0.94304068 |
| 104 | * MP0002069_abnormal_eating/drinking_beha | 0.86579637 |
| 105 | MP0008872_abnormal_physiological_respon | 0.86160673 |
| 106 | MP0006292_abnormal_olfactory_placode | 0.83248533 |
| 107 | MP0005174_abnormal_tail_pigmentation | 0.80389519 |
| 108 | MP0000631_abnormal_neuroendocrine_gland | 0.79989405 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.78289165 |
| 110 | MP0002009_preneoplasia | 0.77268509 |
| 111 | MP0002751_abnormal_autonomic_nervous | 0.77243311 |
| 112 | MP0001663_abnormal_digestive_system | 0.76993522 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.76003938 |
| 114 | MP0001919_abnormal_reproductive_system | 0.75475576 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.75238675 |
| 116 | MP0005671_abnormal_response_to | 0.73478590 |
| 117 | MP0003631_nervous_system_phenotype | 0.70617739 |
| 118 | MP0000569_abnormal_digit_pigmentation | 0.70425924 |
| 119 | MP0003861_abnormal_nervous_system | 0.70175894 |
| 120 | MP0003938_abnormal_ear_development | 0.68492601 |
| 121 | MP0003866_abnormal_defecation | 0.68245619 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.67217535 |
| 123 | MP0002166_altered_tumor_susceptibility | 0.67109441 |
| 124 | MP0002752_abnormal_somatic_nervous | 0.66737118 |
| 125 | MP0002006_tumorigenesis | 0.65658280 |
| 126 | MP0004085_abnormal_heartbeat | 0.64359125 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.63987401 |
| 128 | MP0008260_abnormal_autophagy | 0.63498571 |
| 129 | MP0002019_abnormal_tumor_incidence | 0.63481204 |
| 130 | MP0001963_abnormal_hearing_physiology | 0.61661700 |
| 131 | MP0004142_abnormal_muscle_tone | 0.61376079 |
| 132 | MP0005535_abnormal_body_temperature | 0.61330098 |
| 133 | MP0009765_abnormal_xenobiotic_induced | 0.60481130 |
| 134 | MP0001177_atelectasis | 0.59436626 |
| 135 | MP0004185_abnormal_adipocyte_glucose | 0.58692036 |
| 136 | MP0010769_abnormal_survival | 0.57659733 |
| 137 | MP0002102_abnormal_ear_morphology | 0.56942953 |
| 138 | MP0003303_peritoneal_inflammation | 0.56325336 |
| 139 | MP0000490_abnormal_crypts_of | 0.56300679 |
| 140 | MP0000013_abnormal_adipose_tissue | 0.55422236 |
| 141 | MP0005187_abnormal_penis_morphology | 0.55417284 |
| 142 | MP0000026_abnormal_inner_ear | 0.55030245 |
| 143 | MP0010768_mortality/aging | 0.54912005 |
| 144 | MP0008873_increased_physiological_sensi | 0.52895655 |
| 145 | MP0002082_postnatal_lethality | 0.51304653 |
| 146 | MP0010770_preweaning_lethality | 0.51304653 |
| 147 | MP0000920_abnormal_myelination | 0.51131547 |
| 148 | MP0004484_altered_response_of | 0.49981188 |
| 149 | MP0001348_abnormal_lacrimal_gland | 0.49941337 |
| 150 | MP0002928_abnormal_bile_duct | 0.49857828 |
| 151 | MP0008770_decreased_survivor_rate | 0.49249080 |
| 152 | MP0004808_abnormal_hematopoietic_stem | 0.49212959 |
| 153 | MP0002998_abnormal_bone_remodeling | 0.49187032 |
| 154 | MP0002229_neurodegeneration | 0.48171372 |
| 155 | MP0000427_abnormal_hair_cycle | 0.48149932 |
| 156 | MP0003075_altered_response_to | 0.47536292 |
| 157 | MP0005310_abnormal_salivary_gland | 0.47336627 |
| 158 | MP0002083_premature_death | 0.46836654 |
| 159 | MP0001664_abnormal_digestion | 0.46802376 |
| 160 | MP0001943_abnormal_respiration | 0.46489186 |
| 161 | MP0002098_abnormal_vibrissa_morphology | 0.45783545 |
| 162 | MP0003448_altered_tumor_morphology | 0.45325076 |
| 163 | MP0005464_abnormal_platelet_physiology | 0.44508912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.06560982 |
| 2 | Myokymia (HP:0002411) | 5.74120344 |
| 3 | Focal seizures (HP:0007359) | 5.11243424 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.28899425 |
| 5 | Visual hallucinations (HP:0002367) | 4.05323839 |
| 6 | T lymphocytopenia (HP:0005403) | 3.96251307 |
| 7 | Atonic seizures (HP:0010819) | 3.86729225 |
| 8 | Febrile seizures (HP:0002373) | 3.85863726 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85399540 |
| 10 | Absence seizures (HP:0002121) | 3.72629049 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.72267218 |
| 12 | Abnormality of T cell number (HP:0011839) | 3.69914154 |
| 13 | Broad-based gait (HP:0002136) | 3.67068601 |
| 14 | Abnormality of T cells (HP:0002843) | 3.60879130 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.59937755 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.58461713 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.43395425 |
| 18 | Dialeptic seizures (HP:0011146) | 3.43138978 |
| 19 | Pustule (HP:0200039) | 3.38627300 |
| 20 | IgG deficiency (HP:0004315) | 3.37312759 |
| 21 | Hyperventilation (HP:0002883) | 3.29080597 |
| 22 | Amblyopia (HP:0000646) | 3.19609228 |
| 23 | Stereotypic behavior (HP:0000733) | 3.07858831 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 2.99564678 |
| 25 | Abnormality of eosinophils (HP:0001879) | 2.99524810 |
| 26 | Autoimmune hemolytic anemia (HP:0001890) | 2.93915526 |
| 27 | Myositis (HP:0100614) | 2.92191993 |
| 28 | Excessive salivation (HP:0003781) | 2.90462264 |
| 29 | Drooling (HP:0002307) | 2.90462264 |
| 30 | Stomach cancer (HP:0012126) | 2.84872556 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 2.84458608 |
| 32 | Annular pancreas (HP:0001734) | 2.84423035 |
| 33 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.83950076 |
| 34 | Abnormality of B cell number (HP:0010975) | 2.82659307 |
| 35 | B lymphocytopenia (HP:0010976) | 2.82659307 |
| 36 | Truncal ataxia (HP:0002078) | 2.82002739 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.79264138 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.79264138 |
| 39 | Severe combined immunodeficiency (HP:0004430) | 2.78358229 |
| 40 | Abnormality of the columella (HP:0009929) | 2.78160884 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 2.77753468 |
| 42 | Optic neuritis (HP:0100653) | 2.77753468 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 2.77671332 |
| 44 | Leukocytosis (HP:0001974) | 2.77325208 |
| 45 | Encephalitis (HP:0002383) | 2.75840539 |
| 46 | Poor eye contact (HP:0000817) | 2.73501301 |
| 47 | Basal cell carcinoma (HP:0002671) | 2.73379941 |
| 48 | Recurrent viral infections (HP:0004429) | 2.72246538 |
| 49 | Supranuclear gaze palsy (HP:0000605) | 2.68346796 |
| 50 | Abnormality of binocular vision (HP:0011514) | 2.61642520 |
| 51 | Diplopia (HP:0000651) | 2.61642520 |
| 52 | Impaired social interactions (HP:0000735) | 2.60651201 |
| 53 | Abnormal social behavior (HP:0012433) | 2.60651201 |
| 54 | Abnormality of oral frenula (HP:0000190) | 2.58707475 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.58299427 |
| 56 | Increased IgE level (HP:0003212) | 2.57067889 |
| 57 | Fair hair (HP:0002286) | 2.54451053 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.54387649 |
| 59 | Lymphopenia (HP:0001888) | 2.53260530 |
| 60 | Amyotrophic lateral sclerosis (HP:0007354) | 2.53094684 |
| 61 | Gaze-evoked nystagmus (HP:0000640) | 2.52620962 |
| 62 | Ankyloglossia (HP:0010296) | 2.51804364 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.51218799 |
| 64 | Urinary urgency (HP:0000012) | 2.51047196 |
| 65 | Dysmetria (HP:0001310) | 2.50603598 |
| 66 | Depression (HP:0000716) | 2.49687398 |
| 67 | Anxiety (HP:0000739) | 2.48988804 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.48098368 |
| 69 | Pointed chin (HP:0000307) | 2.47749240 |
| 70 | Genetic anticipation (HP:0003743) | 2.46078944 |
| 71 | Action tremor (HP:0002345) | 2.45050777 |
| 72 | Abnormality of the fingertips (HP:0001211) | 2.44722623 |
| 73 | Granulocytopenia (HP:0001913) | 2.43628315 |
| 74 | Recurrent bronchitis (HP:0002837) | 2.40256180 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 2.40070620 |
| 76 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.37207887 |
| 77 | Impaired smooth pursuit (HP:0007772) | 2.36474836 |
| 78 | Insidious onset (HP:0003587) | 2.34291017 |
| 79 | Termporal pattern (HP:0011008) | 2.34291017 |
| 80 | Verrucae (HP:0200043) | 2.33972215 |
| 81 | Papilloma (HP:0012740) | 2.33972215 |
| 82 | Orchitis (HP:0100796) | 2.33870119 |
| 83 | Meningitis (HP:0001287) | 2.33416548 |
| 84 | Thyroiditis (HP:0100646) | 2.32701118 |
| 85 | Ankle clonus (HP:0011448) | 2.31187801 |
| 86 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.31108938 |
| 87 | Dysdiadochokinesis (HP:0002075) | 2.30957333 |
| 88 | Recurrent skin infections (HP:0001581) | 2.29497535 |
| 89 | Megalencephaly (HP:0001355) | 2.26870707 |
| 90 | Limb dystonia (HP:0002451) | 2.26657262 |
| 91 | Increased IgM level (HP:0003496) | 2.26628238 |
| 92 | Deep palmar crease (HP:0006191) | 2.26538855 |
| 93 | Obstructive sleep apnea (HP:0002870) | 2.24337410 |
| 94 | Progressive inability to walk (HP:0002505) | 2.24018782 |
| 95 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.23919999 |
| 96 | Short 4th metacarpal (HP:0010044) | 2.23919999 |
| 97 | Combined immunodeficiency (HP:0005387) | 2.21717359 |
| 98 | Absent speech (HP:0001344) | 2.21400500 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 2.20269457 |
| 100 | IgM deficiency (HP:0002850) | 2.19099652 |
| 101 | Dysmetric saccades (HP:0000641) | 2.18860639 |
| 102 | Vasculitis (HP:0002633) | 2.16953729 |
| 103 | Chest pain (HP:0100749) | 2.15881500 |
| 104 | Generalized hypopigmentation of hair (HP:0011358) | 2.15497621 |
| 105 | Inappropriate behavior (HP:0000719) | 2.15033525 |
| 106 | Hypochromic anemia (HP:0001931) | 2.13354020 |
| 107 | Keratoconjunctivitis (HP:0001096) | 2.12528754 |
| 108 | Lower limb amyotrophy (HP:0007210) | 2.07942041 |
| 109 | Mutism (HP:0002300) | 2.06549768 |
| 110 | Palpebral edema (HP:0100540) | 2.06234713 |
| 111 | Deeply set eye (HP:0000490) | 2.06084750 |
| 112 | Truncus arteriosus (HP:0001660) | 2.05668683 |
| 113 | Abnormality of T cell physiology (HP:0011840) | 2.03506466 |
| 114 | Lower limb asymmetry (HP:0100559) | 2.03361260 |
| 115 | Autism (HP:0000717) | 2.02929965 |
| 116 | Abnormality of salivation (HP:0100755) | 2.02632715 |
| 117 | Focal dystonia (HP:0004373) | 2.02501615 |
| 118 | Abnormality of the lower motor neuron (HP:0002366) | 2.02381565 |
| 119 | Torticollis (HP:0000473) | 2.02081594 |
| 120 | Epileptiform EEG discharges (HP:0011182) | 2.00368418 |
| 121 | Abnormal eating behavior (HP:0100738) | 1.99153057 |
| 122 | Scanning speech (HP:0002168) | 1.97965314 |
| 123 | Prominent nose (HP:0000448) | 1.97858855 |
| 124 | Hemoptysis (HP:0002105) | 1.97818658 |
| 125 | Mediastinal lymphadenopathy (HP:0100721) | 1.97506469 |
| 126 | Subacute progressive viral hepatitis (HP:0006572) | 1.96179948 |
| 127 | Thickened helices (HP:0000391) | 1.95479968 |
| 128 | Volvulus (HP:0002580) | 1.94072366 |
| 129 | Exotropia (HP:0000577) | 1.93020615 |
| 130 | Slow saccadic eye movements (HP:0000514) | 1.90997662 |
| 131 | Neurofibrillary tangles (HP:0002185) | 1.88481650 |
| 132 | Sporadic (HP:0003745) | 1.88395230 |
| 133 | Abnormal hair whorl (HP:0010721) | 1.87656694 |
| 134 | Apathy (HP:0000741) | 1.86888141 |
| 135 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.86471120 |
| 136 | Eosinophilia (HP:0001880) | 1.85845249 |
| 137 | Pulmonary infiltrates (HP:0002113) | 1.84832119 |
| 138 | Spastic gait (HP:0002064) | 1.84716110 |
| 139 | Hypoplasia of the thymus (HP:0000778) | 1.84082844 |
| 140 | Hemiparesis (HP:0001269) | 1.83892066 |
| 141 | Impaired vibratory sensation (HP:0002495) | 1.83088555 |
| 142 | Chronic diarrhea (HP:0002028) | 1.82941579 |
| 143 | Protruding tongue (HP:0010808) | 1.81693982 |
| 144 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.81534790 |
| 145 | Curly hair (HP:0002212) | 1.81521468 |
| 146 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.81368252 |
| 147 | Prolonged bleeding time (HP:0003010) | 1.81060568 |
| 148 | Inability to walk (HP:0002540) | 1.78895430 |
| 149 | Hypoproteinemia (HP:0003075) | 1.78821792 |
| 150 | Lymphoma (HP:0002665) | 1.78662810 |
| 151 | Long clavicles (HP:0000890) | 1.77086327 |
| 152 | EEG with generalized epileptiform discharges (HP:0011198) | 1.76781084 |
| 153 | Gingivitis (HP:0000230) | 1.76379576 |
| 154 | Tented upper lip vermilion (HP:0010804) | 1.75201374 |
| 155 | IgA deficiency (HP:0002720) | 1.74494060 |
| 156 | Autoimmune thrombocytopenia (HP:0001973) | 1.74465249 |
| 157 | Heterotopia (HP:0002282) | 1.74419325 |
| 158 | Widely spaced teeth (HP:0000687) | 1.74342953 |
| 159 | Cutis marmorata (HP:0000965) | 1.74114537 |
| 160 | Abnormality of the labia minora (HP:0012880) | 1.73226961 |
| 161 | Inflammation of the large intestine (HP:0002037) | 1.72214758 |
| 162 | Obsessive-compulsive behavior (HP:0000722) | 1.72056170 |
| 163 | Distal lower limb amyotrophy (HP:0008944) | 1.71069572 |
| 164 | Gastroesophageal reflux (HP:0002020) | 1.69991964 |
| 165 | Papilledema (HP:0001085) | 1.69627115 |
| 166 | Aqueductal stenosis (HP:0002410) | 1.69083680 |
| 167 | Bowel incontinence (HP:0002607) | 1.67743414 |
| 168 | Insomnia (HP:0100785) | 1.64899390 |
| 169 | Hypsarrhythmia (HP:0002521) | 1.63199901 |
| 170 | Diminished motivation (HP:0000745) | 1.62067240 |
| 171 | Stomatitis (HP:0010280) | 1.61810913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.16528159 |
| 2 | NTRK3 | 4.14525791 |
| 3 | RIPK4 | 3.24997161 |
| 4 | MARK1 | 2.87426535 |
| 5 | SIK2 | 2.78375807 |
| 6 | TXK | 2.55954540 |
| 7 | MAP3K9 | 2.38302551 |
| 8 | NTRK2 | 2.29645932 |
| 9 | MAP3K10 | 2.24886959 |
| 10 | FRK | 2.13083787 |
| 11 | MAP3K4 | 2.12700440 |
| 12 | MINK1 | 2.06139773 |
| 13 | TAOK3 | 1.97358348 |
| 14 | KSR1 | 1.93100233 |
| 15 | WNK3 | 1.84266800 |
| 16 | FES | 1.80275813 |
| 17 | TYRO3 | 1.76556459 |
| 18 | BTK | 1.76025668 |
| 19 | DAPK2 | 1.75520936 |
| 20 | PRPF4B | 1.75032015 |
| 21 | MAP3K13 | 1.74676251 |
| 22 | BMPR2 | 1.69682341 |
| 23 | MAP2K7 | 1.68172223 |
| 24 | KSR2 | 1.66647570 |
| 25 | GRK6 | 1.51873471 |
| 26 | MARK3 | 1.49237906 |
| 27 | DAPK1 | 1.47844593 |
| 28 | TYK2 | 1.47827902 |
| 29 | CDK5 | 1.44384512 |
| 30 | TEC | 1.40594230 |
| 31 | CAMKK1 | 1.38409847 |
| 32 | TNIK | 1.37533513 |
| 33 | CASK | 1.37412157 |
| 34 | MAPK13 | 1.28600675 |
| 35 | PNCK | 1.26492156 |
| 36 | PAK6 | 1.24349434 |
| 37 | MARK2 | 1.22960860 |
| 38 | CSK | 1.22552008 |
| 39 | PLK2 | 1.20226945 |
| 40 | YES1 | 1.18378386 |
| 41 | JAK1 | 1.17659408 |
| 42 | MAP4K1 | 1.16034813 |
| 43 | CAMK2B | 1.13363777 |
| 44 | MAP3K7 | 1.12152071 |
| 45 | RAF1 | 1.11725329 |
| 46 | BRD4 | 1.11555872 |
| 47 | CDK12 | 1.11194750 |
| 48 | IRAK4 | 1.07872395 |
| 49 | PRKD3 | 1.07300966 |
| 50 | STK11 | 1.06739387 |
| 51 | PRKCH | 1.05500408 |
| 52 | PRKCQ | 1.02162778 |
| 53 | TAOK1 | 1.01386255 |
| 54 | JAK3 | 1.01057244 |
| 55 | LYN | 0.99966028 |
| 56 | MAP3K12 | 0.99296445 |
| 57 | MAP3K2 | 0.96453693 |
| 58 | TNK2 | 0.95626770 |
| 59 | MAP2K4 | 0.92873289 |
| 60 | PRKCG | 0.92545475 |
| 61 | FGFR2 | 0.92054669 |
| 62 | CAMK2A | 0.90580182 |
| 63 | MAP3K14 | 0.89702176 |
| 64 | PASK | 0.88966286 |
| 65 | NME1 | 0.88105865 |
| 66 | BLK | 0.87205100 |
| 67 | TRIM28 | 0.86400102 |
| 68 | ITK | 0.86066748 |
| 69 | PRKD2 | 0.85009498 |
| 70 | DYRK1A | 0.84395180 |
| 71 | PIM1 | 0.84290009 |
| 72 | SYK | 0.83328916 |
| 73 | IRAK1 | 0.82594306 |
| 74 | UHMK1 | 0.82442214 |
| 75 | PTK2B | 0.78405165 |
| 76 | FGR | 0.77914530 |
| 77 | STK38 | 0.77602266 |
| 78 | HCK | 0.76733349 |
| 79 | SGK2 | 0.75383235 |
| 80 | NTRK1 | 0.74934033 |
| 81 | ARAF | 0.74752238 |
| 82 | SGK1 | 0.73040218 |
| 83 | GRK5 | 0.72038390 |
| 84 | DMPK | 0.70816343 |
| 85 | JAK2 | 0.70043423 |
| 86 | FYN | 0.69126632 |
| 87 | CAMKK2 | 0.68740025 |
| 88 | FGFR3 | 0.66541031 |
| 89 | CAMK1 | 0.65770576 |
| 90 | SGK3 | 0.64455863 |
| 91 | CSNK1G2 | 0.62830594 |
| 92 | SGK223 | 0.62608073 |
| 93 | SGK494 | 0.62608073 |
| 94 | RET | 0.62207810 |
| 95 | IKBKB | 0.60867538 |
| 96 | BCR | 0.59690930 |
| 97 | DYRK1B | 0.58664931 |
| 98 | PDK1 | 0.58547539 |
| 99 | CDK18 | 0.57950036 |
| 100 | CDK19 | 0.56013972 |
| 101 | CDK15 | 0.55190969 |
| 102 | CDK6 | 0.55092723 |
| 103 | PDGFRB | 0.54724486 |
| 104 | CDK14 | 0.54173027 |
| 105 | CDK4 | 0.54154745 |
| 106 | SIK3 | 0.52559279 |
| 107 | CAMK4 | 0.52407797 |
| 108 | MKNK2 | 0.50580878 |
| 109 | ERBB3 | 0.50250395 |
| 110 | CDK11A | 0.49143408 |
| 111 | AKT3 | 0.48695159 |
| 112 | MAPK10 | 0.46600048 |
| 113 | EPHB1 | 0.46409326 |
| 114 | MAPK12 | 0.45899182 |
| 115 | ALK | 0.45189438 |
| 116 | WNK1 | 0.45165800 |
| 117 | NLK | 0.44871981 |
| 118 | EEF2K | 0.44331043 |
| 119 | MAP3K6 | 0.44200672 |
| 120 | LCK | 0.44067230 |
| 121 | STK4 | 0.43918549 |
| 122 | PRKCZ | 0.43456146 |
| 123 | MAP3K1 | 0.42285561 |
| 124 | IRAK2 | 0.39581877 |
| 125 | NEK6 | 0.38781602 |
| 126 | ACVR1B | 0.38279886 |
| 127 | PRKCB | 0.38183705 |
| 128 | MAPK7 | 0.38058025 |
| 129 | EPHA3 | 0.37484411 |
| 130 | CLK1 | 0.37480186 |
| 131 | PAK3 | 0.36890946 |
| 132 | HIPK2 | 0.35369630 |
| 133 | RPS6KA3 | 0.35228111 |
| 134 | MAPK9 | 0.34208504 |
| 135 | MAPK8 | 0.33225858 |
| 136 | ZAP70 | 0.32571077 |
| 137 | IKBKE | 0.32413773 |
| 138 | FGFR4 | 0.31562823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.18446928 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.86910324 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.80820951 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.44351507 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.39822907 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.36157909 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.36018500 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.34935593 |
| 9 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13107911 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.07960610 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.98780786 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.94426697 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.88883529 |
| 14 | Renin secretion_Homo sapiens_hsa04924 | 1.87947549 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81739500 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71322541 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.69706185 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.69679399 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68085800 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66913821 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63203411 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59376902 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.58686471 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.57603575 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.56063531 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.53223335 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.50332813 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50252556 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50207495 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45034384 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42081630 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40206533 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40150328 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.39234878 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.38941109 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.38845810 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38724107 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.37410708 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.36812642 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33607022 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31906238 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29915845 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28682284 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.27962181 |
| 45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23391548 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.21223370 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 1.19807607 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.14451308 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13652901 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11143047 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10579909 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06396817 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03067060 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98073060 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97777693 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97089025 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.96925772 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.96502064 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.95695332 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94759709 |
| 61 | Prostate cancer_Homo sapiens_hsa05215 | 0.94585416 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94302774 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94274965 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93159856 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92023460 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91070211 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88729715 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87109652 |
| 69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86596669 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.86033610 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85468463 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85466437 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.85297135 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85055130 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83257494 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81316637 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.79209466 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79165966 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78540468 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78201265 |
| 81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75482426 |
| 82 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.75253789 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73974284 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72990855 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72955565 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72598943 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71620261 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71562108 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71497252 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.71337435 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.70767898 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70403249 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70180034 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70010471 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67512166 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64444542 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63991540 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63889266 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63771874 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.63734171 |
| 101 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62600882 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61943354 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60525461 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58714386 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.57829111 |
| 106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56623277 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56606725 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55936698 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55640381 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55627216 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55155495 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53894785 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53587859 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53306107 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52129654 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.52037940 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51561618 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51170368 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50771153 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50664390 |
| 121 | Malaria_Homo sapiens_hsa05144 | 0.50577626 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50410486 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50211558 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49731665 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49124259 |
| 126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47877045 |
| 127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47302428 |
| 128 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47032920 |
| 129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46740845 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.46277902 |
| 131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46077522 |
| 132 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.45391299 |
| 133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44330916 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42565161 |
| 135 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42125480 |
| 136 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42078392 |
| 137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41330316 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38523298 |
| 139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37860344 |

